OPINION: drug firms say no to rebates, despite billions in new revenue from Part D

By Wendell Potter

Part D brought drug companies billions, but they say the sky is falling

Excerpts from this story referencing "Pfizer":

"… ld, that translates into serious cash going into the pockets of investors. Pfizer’s most recently reported profit margin, for example, was 24.7 percent. A …"

Drug lobby donation went to pro-Democratic nonprofit

By Michael Beckel

Half-million-dollar donation from PhRMA went to little-known group that backed Harry Reid.

Excerpts from this story referencing "New York":

"… public relations firm Hilltop Public Solutions, which has offices in D.C., New York and Billings, Mont.Little is known about the group, but Internal Revenue S …"

Federal regulators have failed to act on toxic chemical, report says

By Chris Hamby

Regulators have done little to protect the public from BPA, critics say

Report faults Medicare controls on widely abused drugs

By Joe Eaton

Beneficiaries easily went to multiple doctors for hydrocodone and oxycodone

Inspectors struggle to keep up with flood of imports

By Brad Racino

Food imports approved for use in the U.S. in an unexpected way

Excerpts from this story referencing "China":

"… n, tapioca pearls from the Philippines and tea biscuits and bean curd from China.The shipments were flagged for inspection as they came in through one of t …"

"… nold Shih and Dennis Hoang watched as 50 boxes of preserved bean curd from China were emptied into a grinding machine.The monstrously loud apparatus worked …"

"… it has opened offices in several large food-exporting countries, including China, India and Costa Rica, and has boosted the number of inspections in other …"

Investigations Around the World

By Simona Raetz

Drug on wars makes pain killers unavailable for patients in developing countries; mining companies are big winners of Chilean tax system

FDA's flimsy recall power for food imports puts public at risk, watchdog says

By Aaron Mehta and Ben Wieder

FDA needs more power to police recalls of imported foods

FDA screening of fish imports not catching antibiotics and drug residue

By Laurel Adams

FDA taken to task for sloppy inspections of imported fish

During Mitch Daniels’ decade at Eli Lilly, the drug giant paid billions in fines and settled thousands of lawsuits

By Joanne Kenen and Rochelle Sharpe

Eli Lilly paid billions in fines, settled thousands of lawsuits while Daniels was an executive at the drug giant

Excerpts from this story referencing "San Diego":

"… e was taking Zyprexa. "I just thought his appetite had increased," saidthe San Diego woman. She didn’t realize her son had developed severe hyperglycemia, ab …"

Medicare can’t identify top prescribers of addictive drugs

By The Center for Public Integrity and Joe Eaton

Medicare doesn't know if all the prescriptions it is paying for are being written by real doctors, says a new inspector general's report....

Excerpts from this story referencing "Delaware":

"… ugh, they say it’s difficult to know which is which.Sen. Tom Carper, the Delaware Democrat who requested the OIG investigation, was troubled by the results. …"

FDA criticized for accepting free help from company that later won generic OK

By Laurel Adams

The Food and Drug Administration last month issued guidelines for agency staff to follow when drugmakers offer free help during emergencies

Excerpts from this story referencing "Joe Barton":

"… ort, which does not mention Momenta Pharmaceuticals, was requested by Rep. Joe Barton of Texas, the senior Republican on the House Energy and Commerce Committee …"

In health, like everything else, men and women really are different

By Amy Biegelsen

Health studies still do not adequately root out differences between men and women, according to a new report from the National Academy of Sc

Most drug trial results analyzed by FDA hidden from view

By Naseem Miller

Before a new drug finds its place on pharmacy shelves or a new device lands in the hands of a surgeon, it goes through a long and complex ap

FDA lags USDA in accessible food safety data

By Jim Morris

Recent outbreaks of food-borne illness left American consumers on edge — and largely in the dark about federal enforcement. The Food and Dru

FDA reaches agreement with firm that produced troubled heart drug

The U.S. Food and Drug Administration last week announced a little-noticed tentative agreement setting conditions under which a troubled pha

Did the FDA miss signals on a troubled heart drug?

By Jeanne Lenzer

It has been a rough eight months for the drug maker Actavis, Inc. and its powerful heart drug, Digitek. Following repeated Food and Drug Adm

Excerpts from this story referencing "prominent cardiologist":

"… te that Digitek could be the source of serious problems. David L. Brown, a prominent cardiologist at the SUNY-Stony Brook School of Medicine, said that the tablets could po …"

FDA enforcement actions way down

By The Center for Public Integrity

Enforcement actions by the (FDA) markedly declined under the Bush administration

Lack of adequate foreign drug oversight

By The Center for Public Integrity

The GAO called for improvement in the FDA’s Foreign Drug Inspection Program in 1998. A decade later, there's been little improvement.

FDA failure to ensure drug safety

By The Center for Public Integrity

Vioxx dangers raise questions about FDA's ability to monitor drugs

More big money from pharmaceutical lobby in 2008

By Mary Beth Lombardo

The economy may be sliding, but that hasn’t stemmed the high-rolling habits of Washington’s largest lobby. In 2007, as the Center recently r

A record year for the pharmaceutical lobby in '07

By M. Asif Ismail

Washington's largest lobby racks up another banner year on Capitol Hill

Excerpts from this story referencing "Prescription Drug User Fee Act":

"… try had better luck with two other laws it lobbied robustly to extend, the Prescription Drug User Fee Act and the Best Pharmaceuticals for Children Act. Both were reauthorized in t …"

Spending on lobbying thrives

By M. Asif Ismail

Drug and health products industries invest $182 million to influence legislation

Excerpts from this story referencing "Manufacturers of America":

"… h advocacy group.The drug industry trade group Pharmaceutical Research and Manufacturers of America (PhRMA) spent more than $18 million on lobbying last year, more than any s …"

PEPFAR policy hinders treatment in generic terms

By M. Asif Ismail

Critics say FDA approval rule has meant greater use of high-cost drugs at expense of helping fewer patients

Drug makers' dime funds Congressional travel

By Robert Brodsky

Pharmaceutical companies, affiliated trade groups spent more than $600,000 on trips

Excerpts from this story referencing "Orrin Hatch":

"… aign but refused to discuss details.A personal connectionFor example, Sen. Orrin Hatch, R-Utah, and his aides took seven trips, totaling $12,000, sponsored by Pf …"

Deep pockets contribute to success

By M. Asif Ismail

Industry spends millions on state campaign donations, Calif. fight

Excerpts from this story referencing "Gray Davis":

"… argest individual recipients of campaign money from the industry. Democrat Gray Davis, California's former governor, was the top individual recipient identified …"

States see importation as solution to high drug costs

By Victoria Kreha

Several seek, have plans despite federal and industry opposition

Excerpts from this story referencing "Manufacturers of America":

"… nbsp;reported in January 2005, the trade group Pharmaceutical Research and Manufacturers of America hired Gordon Giffin, the former U.S. Ambassador to Canada, to lobby in tha …"

FDA staff travels on drug industry dollars

By Alexander Cohen

Groups tied to FDA-regulated industry paying for agency officials' trips

Excerpts from this story referencing "pharmaceutical industry":

"… — I don't know if that's proper."Two other universities with ties to the pharmaceutical industry together sponsored more than 100 trips costing roughly $98,000. The Univer …"

Drug lobby second to none

By M. Asif Ismail

How the pharmaceutical industry gets its way in Washington

Excerpts from this story referencing "Pfizer":

"… cap prescription drug prices, which would have dented their profit margins.Pfizer, the world's largest drug company, made a profit of $11.3 billion last yea …"

Surrogates for their agenda

By Alexander Cohen

How the drug industry uses non-profits to push its interests

Excerpts from this story referencing "Plus Association":

"… the state.The year before, Bonner and Associates had teamed up with the 60 Plus Association to run a phone campaign on Pfizer's behalf that urged Minnesota constituen …"

Checkbook politics

By Victoria Kreha

Over the last seven years, the pharmaceutical industry has given $150 million in campaign contributions

Excerpts from this story referencing "Center for Responsive Politics":

"… Public Integrity analysis of campaign finance records provided by the Center for Responsive Politics and the Institute on Money in State Politics. Sixty-five percent …"

"… deral campaign contributions, the Center used research by the non-partisan Center for Responsive Politics, based in Washington, D.C. The analysis on state political donations was b …"